This study is the first to reveal the implications of DS mutations in Scn1a on the incidence and mechanisms of arrhythmias and SUDEP due to changes in cardiac myocyte excitability, and suggest targets for risk assessment and intervention to prevent SUDEP in DS and perhaps other epileptic channelopathies. Here, SCN1A is linked to Dravet syndrome.